We hypothesized that the silent cerebral infarcts (SCI), which affect up to 40% of children with sickle cell disease (SCD), could occur in the setting of acute anemic events.
Introduction
Stroke is a major cause of disability in children with sickle cell disease (SCD), with clinically apparent stroke occurring in 10% in the absence of primary prevention. A larger percentage (20% to 40%) suffer smaller strokes that do not produce obvious neurologic symptoms termed "silent cerebral infarcts" (SCI). These lesions actually are associated with significant cognitive impairment, 1,2 can be progressive, 3 and increase the risk of subsequent overt stroke. 4 By their "silent" nature, the onset of SCI is unknown, but acute silent cerebral ischemic events (ASCIE) can be detected during the acute or subacute phase by magnetic resonance imaging (MRI) using diffusion weighted imaging (DWI). 5, 6, 7 The unique features of DWI allows differentiation of strokes occurring acutely (within 0 to 14 days) from more remote events.
We previously reported ASCIE as incidental MRI findings in 7 children with SCD; 4
were associated with acute anemic events 6 related to viral-induced aplastic crisis or splenic sequestration, when there is a precipitous drop in the otherwise stable chronic anemia of SCD. [8] [9] [10] [11] [12] The resultant decrease in oxygen delivery to the brain due to severe anemia could lead to clinically silent ischemic injury, just as acute anemic events are known to be a risk factor for clinically overt stroke in children with SCD. 12 We suspected that similar events (ASCIE) could occur in children without SCD when they experienced acute severe anemia. We hypothesized that ASCIE, which by definition are not recognized clinically, often occur during episodes of acute anemia. In this prospective observational study, we screened children with acute, severe anemia, both with and without SCD, for ASCIE using DWI. Our secondary hypothesis was that these
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Patients and methods

Patients and Imaging Studies
With the approval of the UT Southwestern Institutional Review Board and in accordance with the Declaration of Helsinki, we prospectively screened all children from 2 to19 years of age admitted to Children's Medical Center Dallas with severe anemia over a 30 month period from October 2007 to April 2010. Laboratory studies were manually reviewed daily for inpatients (excluding patients in the Neonatal and Cardiovascular
Intensive Care Units) to identify children with low hemoglobin concentrations. We included children, both with and without SCD, who had severe anemic events defined as a hemoglobin concentration ≤ 5.5 g/dl regardless of etiology, with at least a 30% decrease from their clinically established baseline for children with a known chronic anemia. This value was chosen empirically based on prior observations of silent infarction in the setting of severe anemia, 6 hemoglobin concentrations observed in our population of children with SCD during acute anemic events, and the clinical judgment of the study hematologists.
By the nature of the screening process, we were unable to assess the rapidity of the decline in hemoglobin concentration. We excluded children with a history of traumatic head injury in the prior 2 weeks, a reported history or clinical examination finding of new focal neurologic deficits of >24 hours duration, a clinical condition precluding transport, or contraindication for MRI. The exclusion for focal neurologic abnormalities applied (that is, two MRIs separated in time were not required for each patient) expressed as the number of events per 100 patient years of observation. 7 We calculated these estimated incidence rates for ASCIE from the single DWI scans based on the estimate that each DWI provided 10 days of patient observation because, after a stroke, the DWI signal becomes abnormal within hours and persists for 7 to 14 days. [20] [21] [22] As a secondary analysis, we also calculated estimated incidence rates based on 7 and 14 days of observation. As these incidence rates are derived from single observations and the duration of positive DWI signal may vary, we report these as estimated incidence rates or as approximate (~) in the tables. Data were analyzed using IBM SPSS Statistics 19 and MedCalc version 11.
Results
Enrollment and Etiologies of Anemia
During the 30 month study period, 58 children met criteria and consented to participate. with SCI in locations corresponding to the ASCIE on the initial study MRI (Table 1) and thus meet the definition of acute SCI. All 3 had SCD. Notably, the patient without a corresponding lesion on follow up imaging also had no FLAIR correlate on the initial study MRI. This patient did not have SCD. We believe this to be a transient, reversible ASCIE. 7 Magnetic resonance angiography (MRA) was not part of our study protocol but was obtained for the clinically-indicated follow-up studies for 4/6 of the patients with ACSIE and was normal in 3, with one patient demonstrating subtle vascular irregularities in the internal carotid artery and middle cerebral artery ipsilateral to the ASCIE ( Table 1) .
Incidence of ASCIE ASCIE were identified overall in 6/52 (11.5%) MRI studies performed. Given that each DWI study provides an estimated 10 patient days of observation for acute ischemic events, this corresponds to an overall estimated ASCIE incidence of 421 (95% C.I. 155-920) ASCIE per 100 patient years. For children with SCD, the estimated incidence was 663 (95% C.I. 182-1707) ASCIE per 100 patient years, and was lower for children without SCD, 243 (95% C.I. 30-881) ASCIE per 100 patient years ( PedNIHSS=1 for language abnormalities, the other had PedNIHSS=1 for visual field deficit). PSOM scores ranged from 0.5 to 3 (out of the maximum score of 10) and in general corresponded to mild deficits without significant functional impairment in individual domains. Total PSOM scores were 0.5 for six children, 1 for two children, 2
for one child, and 3 for one child. Abnormalities were primarily in the cognitive behavioral domain of the PSOM but some subtle sensory-motor and language deficits were also noted. Only 2 children with ASCIE had abnormalities noted at presentation.
One had PSOM=0.5 for a mild language production deficit and the other had PSOM=1 for moderate cognitive deficits. One child with ASCIE did not have a formal neurologic examination at presentation, but had a normal examination at follow-up.
Follow up neurologic examination was performed 1 to 12 months following presentation.
Of the 10 children with abnormalities on initial examination, 8 showed improvement with lower PSOM score (5 had normal follow up examination) while one worsened and one was lost to follow up. However, new abnormalities on examination were noted in 7 children who had normal examinations at presentation. Abnormalities at follow up were overall less severe, with 11 children having PSOM scores ranging from 0.5 to 3, with PSOM=0.5 for seven children, PSOM=1 for one child, PSOM=1.5 for two children and
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Of the two children with ASCIE who had abnormalities on initial exam, one had improvement in PSOM score (cognitive deficit) decreasing from 1 (moderate) at presentation to 0.5 (mild), the other was lost to follow-up. Three others with ASCIE who had normal exam at presentation remained normal and one was lost to follow-up. There were no significant differences in the proportions of children with abnormalities on examination between the children with and without ASCIE at either time point (Table 2) .
Discussion
Previously identified risk factors for silent infarction in SCD include a lower pain event rate, history of seizures, increased leukocyte count, and Senegal beta globin haplotype 24 but not severe anemia. A more recent study identified gender, high systolic blood pressure and a low baseline hemoglobin as risk factors for SCI. 25 Acute anemic events are an identified risk factor for overt stroke in children with SCD. Such events, usually due to parvovirus B19 infection, hyperhemolysis or splenic sequestration, frequently complicate the otherwise stable chronic anemia of SCD. 8 Severe anemia, either acutely proximate to the stroke 9 or in the steady state 10,11 increases the risk for overt stroke.
Compelling evidence of this relationship is provided in a retrospective review of 346 acute anemic events suffered by SCD patients, where the crude risk of overt stroke during the subsequent 5 weeks was 58 times greater than expected. 12 We identified ASCIE in 4/22 (18.22%) of children with SCD and in 2/30 (6.7%) of children without SCD who presented with severe anemic events. The observed ASCIE
For personal use only. on October 24, 2017. by guest www.bloodjournal.org From estimated incidence rate is much higher than the incidence reported for either overt or silent strokes in other studies of SCD (Table 3 ). The estimated incidence rate for ASCIE in our study population of children with SCD and an exacerbation of their anemia is over 1000 times greater the incidence of overt stroke in SCD 26 and 650 times greater than the reported incidence of SCI. 3 It is 22 times greater than the rate of overt stroke during the 5 weeks following acute anemic events. 12 Even with the most conservative estimate of the duration of the DWI signal abnormality (30 days), the estimated incidence in our SCD group of 221 ASCIE per 100 patient years remains much higher than the reported incidence of other ischemic events in children with SCD.
ASCIE are rarely detected in children with or without SCD who undergo MRI when they are clinically stable. The demonstrated temporal association of ASCIE and severe anemia in this study suggests that a significant proportion of SCI in children with SCD may be occurring in the setting of acute illnesses characterized by worsening of anemia. This is also supported by prior reports of ASCIE in association with severe anemia 6,27,5 or those of SCI associated with acute chest syndrome. 28 Most SCI observed in patients with SCD occur in the deep subcortical white matter, not directly in the area supplied by the internal carotid artery or its branches, as would be expected for an embolic phenomenon.
Rather, SCI occur in the watershed or border zone regions, which are at highest risk of hypoperfusion or hypoxia during severe anemia. 27 The high incidence of ASCIE observed during severe anemia in our study, in this same watershed distribution, is suggestive of a causal association. However, it is possible that other etiologies could account for these findings, such as co-incident hypoxia, transfusion-related events, perhaps related to paradoxical embolization or MRI changes related to posterior 28 Cerebral vasculopathy could also contribute to ischemia, especially in the setting of severe anemia. However, while MRA was not part of our study protocol, of 4 patients with ASCIE who subsequently had a clinically indicated MRA, 3 had no evidence of cerebral vasculopathy, and one had only a subtle vascular irregularity ipsilateral to the lesion. This small number of MRA studies in our study precludes further speculation, but warrants further observation.
Prior studies did not use DWI for the calculation of incidence rates. However, a similar calculation was performed using the large number of DWI studies obtained as part of the ongoing Silent Infarction Transfusion Trial (SITT) where ASCIE were observed in 10 of 771 (1.3%) DWI studies, yielding a baseline incidence rate of 47.3 (95% C.I. 22.7-87.2) ASCIE per 100 patient years in clinically stable children with SCD. 7 Notably, one of the 10 patients with ASCIE in that study was admitted 5 days prior to the DWI for acute chest syndrome with associated severe anemia. The others had no antecedent medical events. In this present study the observed ASCIE estimated incidence rate during severe anemia is 14 times greater than that observed in SITT where the majority of the patients were at their clinical baseline. Therefore, as for overt stroke, 11 there may be two distinct clinical settings for ASCIE/SCI: 1) those which occur at the time of or 2) in the absence of, antecedent or concurrent medical events such as an acute exacerbation of anemia.
Risk factors, recurrence rates, and optimal treatment approaches for the two groups may differ.
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The term "silent" cerebral infarction is a misnomer, as previously noted 1,2,13-16 but is the current standard in the field to describe these small lesions with no obvious focal findings. Our observations demonstrate that "silent" may be more a matter of the depth of the investigation. The PedNIHSS was relatively insensitive, with abnormal scores for only 2 of the children while the PSOM was more sensitive, with abnormalities in 10 of the 48 children examined at presentation. The majority of these findings were in the cognitive-behavioral domain. Such abnormalities, in general, do not localize well and thus are difficult to attribute to an individual lesion, as may be possible with focal motor, sensory or language deficits. More detailed neuropsychiatric evaluation was beyond the scope of this study. Careful examination and more detailed follow up evaluation may be warranted for children with severe anemia with subtle findings or cognitive changes.
We also observed ASCIE in two children with severe anemia without SCD. To our knowledge, ASCIE have not been previously reported in prospective studies of children without SCD. Iron deficiency anemia is an established risk factor for overt stroke in children, although other factors such as an associated thrombocytosis may apply. 29 In one study, previously healthy children with overt stroke were 10 times more likely to have iron-deficiency anemia than healthy children without stroke. 29 These iron-deficient children accounted for more than half of all overt stroke cases in children without other underlying illnesses. Thus, in children with conditions associated with severe anemia, "silent" brain injury could occur and cause neurocognitive impairment that might erroneously be attributed to the treatments or medications for their primary disorder.
ASCIE may be reversible. Evidence of permanent brain injury (SCI) was noted on follow up imaging study in 3 of 4 cases. One had no corresponding lesion on the follow up MRI. The SITT study also demonstrated that that ASCIE occur more frequently than SCI, suggesting that the ischemic injury in children with SCD detectible by DWI may be reversible or result in lesions below the level of detection by MRI. 7 Our observations also support this potential reversibility. Many of our patients had abnormalities on formal neurologic examination and whether they had ASCIE or not, most showed improvement at follow up. Some of this dysfunction could be related to sub-threshold or reversible brain ischemia caused by their severe anemia. Further investigation is needed to determine if closer monitoring and more rapid recognition and treatment of severe anemia can prevent or reverse ASCIE.
Our study is limited by the small number of children with severe anemia able to undergo MRI, due to their age or clinical status. Several were found to have evidence of prior SCI and thus may have represented a group at increased risk for recurrent SCI. 3 We were unable to define the rapidity of decline of the hemoglobin concentration. There may be differences in the risk of ischemic brain injury for those with more sudden decreases in hemoglobin concentration. This may be more relevant for children without SCD where baseline hemoglobin concentrations were unknown and their clinical conditions may have resulted in a slower decline to below our study threshold. Further, most of the children were acutely ill with other disorders in addition to their severe anemia which could have contributed to cerebral hypoxia or hypoperfusion and complicate the interpretation of our results. Nevertheless, we screened all children admitted to our center over a 30 month period for severe anemia and attempted to enroll all eligible children. For patient safety reasons and delays in identification and consent, we were unable to perform formal neurologic examinations prior to transfusion or imaging. The study neurologist was not specifically blinded to the etiology or MRI results as he was frequently involved in their clinical care. We did, however, identify neurologic abnormalities that had not been noted on routine clinical evaluation.
The temporal qualities of the DWI signal, which rapidly (<24 hours) and transiently (for only 7-14 days) permits identification of areas of ischemic brain injury, allowed us to demonstrate a strong temporal association between ASCIE and severe anemia in this prospective observational study. We identified clinically unsuspected evidence of acute ischemic brain injury (ASCIE) in almost one fifth of children with SCD who presented with an exacerbation of their chronic anemia, occurring at an estimated incidence rate that is from 14 to 650 times higher than that reported for silent ischemic events in clinically stable children with SCD. The temporal association of ASCIE with severe anemia and the plausible mechanism of a decrease in brain oxygen delivery in the setting of severe anemia support, but do not establish, a causal association between ASCIE and anemia. This is further supported by our observation that ASCIE occur more frequently in SCD in the setting of severe exacerbation of anemia compared to the baseline, chronically anemic steady-state. Some ASCIE appear to be reversible. Anemic events are common and recurrent in children with SCD and this could partially account for the high prevalence of SCI in children with SCD. ASCIE were also observed in children without SCD and some of these events may also be reversible. Alterations in management may be warranted for all children with severe anemia to identify and ameliorate or reverse unrecognized ischemic brain injury.
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